In agreement with previous studies we found the ASAs (Jo-1 and non-Jo-1), PMScl and anti-MDA5 to be significantly associated with ILD, with the non-Jo-1 ASA positive patients having an even greater risk of lung involvement than the Jo-1 positive patients [21,44]. Here, IFIH1 is linked to interstitial lung disease.